Analytical Data
-
基因名
CTP
- Application
-
别名
SLC25A1; SLC20A3; Tricarboxylate Transport Protein; Solute Carrier Family 25 Member 1; Tricarboxylate carrier protein; Citrate transport protein
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P53007
-
表达区间
Lys19~Asp311
-
分子量
36kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTP (Cytosine Triphosphate) recombinant proteins have gained significant attention in the field of molecular biology and biotechnology due to their diverse applications in research and industry. The background of CTP recombinant protein studies can be traced to the need for effective tools in understanding cellular processes, therapeutic development, and vaccine production. By utilizing recombinant DNA technology, scientists can insert the CTP gene into host cells to produce proteins with specific characteristics, enabling the study of their biological functions and facilitating the development of novel therapies. For instance, CTP proteins are essential in nucleotide metabolism and are implicated in various diseases, making them important targets for drug discovery. Furthermore, the ability to produce these proteins in large quantities and with high purity is crucial for both basic research and clinical applications. As research progresses, advancements in expression systems and purification techniques continue to improve the efficiency and efficacy of CTP recombinant protein production. These innovations not only enhance our understanding of fundamental biological mechanisms but also open up new avenues for therapeutic interventions and biotechnological advancements, solidifying the significance of CTP recombinant proteins in contemporary biological research.












